BN Business News
Add your company to Business Communicator →

Business · 09/06/2004

FDA Approves New Dosage Forms for Clindamycin in Dogs

The FDA is updating its animal drug regulations to reflect the approval of two new dosage forms for clindamycin, a prescription antibiotic, for treating certain bacterial diseases in dogs. These updates include a higher dose range and a new 300-milligram capsule size for the treatment of bacterial diseases in dogs.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights